K(ATP)-mediated vasodilation is impaired in obese Zucker rats. 2008

Benjamin L Hodnett, and Lusha Xiang, and Jennifer A Dearman, and Cory B Carter, and Robert L Hester
Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi 39216-4505, USA.

OBJECTIVE Skeletal muscle blood flow during exercise is impaired in obesity. We tested the hypothesis that the attenuated vasodilation in skeletal muscle arterioles of obese Zucker rats (OZR) is due to altered K(ATP) channel-mediated vasodilation. METHODS K(ATP) channel function was determined in isolated skeletal muscle arterioles in response to the K(ATP) opener cromakalim (0.1-10 microM) during normal myogenic tone and alpha-adrenergic-mediated tone (0.1 microM phenylephrine). The spinotrapezius muscle was prepared and the vasodilatory responses to muscle stimulation or iloprost (0.028-2.8 microM) were observed before and after the application of the K(ATP) inhibitor, glibenclamide (10 microM). Channel subunit expression was determined by using western blot analyses. RESULTS Cromakalim concentration-response curves were shifted in OZR as compared to lean controls. OZR exhibited impaired functional and iloprost-induced vasodilation as compared to the lean controls. Glibenclamide inhibited the functional and iloprost-induced dilation in the lean rats with no effects in the obese a nimals. Channel subunit expression was similar in femoral arteries. CONCLUSIONS The impaired functional vasodilation in the OZR is associated with altered K(ATP) channel sensitivity.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010656 Phenylephrine An alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant, and cardiotonic agent. (R)-3-Hydroxy-alpha-((methylamino)methyl)benzenemethanol,Metaoxedrin,Metasympatol,Mezaton,Neo-Synephrine,Neosynephrine,Phenylephrine Hydrochloride,Phenylephrine Tannate,Neo Synephrine,Tannate, Phenylephrine
D011924 Rats, Zucker Two populations of Zucker rats have been cited in research--the "fatty" or obese and the lean. The "fatty" rat (Rattus norvegicus) appeared as a spontaneous mutant. The obese condition appears to be due to a single recessive gene. Zucker Rat,Zucker Rats,Rat, Zucker
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005905 Glyburide An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide Glibenclamide,Daonil,Diabeta,Euglucon 5,Euglucon N,Glybenclamide,HB-419,HB-420,Maninil,Micronase,Neogluconin,HB 419,HB 420,HB419,HB420
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001160 Arterioles The smallest divisions of the arteries located between the muscular arteries and the capillaries. Arteriole
D014662 Vasoconstrictor Agents Drugs used to cause constriction of the blood vessels. Vasoactive Agonist,Vasoactive Agonists,Vasoconstrictor,Vasoconstrictor Agent,Vasoconstrictor Drug,Vasopressor Agent,Vasopressor Agents,Vasoconstrictor Drugs,Vasoconstrictors,Agent, Vasoconstrictor,Agent, Vasopressor,Agents, Vasoconstrictor,Agents, Vasopressor,Agonist, Vasoactive,Agonists, Vasoactive,Drug, Vasoconstrictor,Drugs, Vasoconstrictor

Related Publications

Benjamin L Hodnett, and Lusha Xiang, and Jennifer A Dearman, and Cory B Carter, and Robert L Hester
April 2008, American journal of physiology. Heart and circulatory physiology,
Benjamin L Hodnett, and Lusha Xiang, and Jennifer A Dearman, and Cory B Carter, and Robert L Hester
February 2005, American journal of physiology. Heart and circulatory physiology,
Benjamin L Hodnett, and Lusha Xiang, and Jennifer A Dearman, and Cory B Carter, and Robert L Hester
February 2009, American journal of physiology. Regulatory, integrative and comparative physiology,
Benjamin L Hodnett, and Lusha Xiang, and Jennifer A Dearman, and Cory B Carter, and Robert L Hester
December 2002, Diabetes,
Benjamin L Hodnett, and Lusha Xiang, and Jennifer A Dearman, and Cory B Carter, and Robert L Hester
September 2011, American journal of physiology. Heart and circulatory physiology,
Benjamin L Hodnett, and Lusha Xiang, and Jennifer A Dearman, and Cory B Carter, and Robert L Hester
November 2003, American journal of physiology. Regulatory, integrative and comparative physiology,
Benjamin L Hodnett, and Lusha Xiang, and Jennifer A Dearman, and Cory B Carter, and Robert L Hester
February 2014, Cardiovascular diabetology,
Benjamin L Hodnett, and Lusha Xiang, and Jennifer A Dearman, and Cory B Carter, and Robert L Hester
September 1997, Clinical science (London, England : 1979),
Benjamin L Hodnett, and Lusha Xiang, and Jennifer A Dearman, and Cory B Carter, and Robert L Hester
December 2006, Hypertension (Dallas, Tex. : 1979),
Benjamin L Hodnett, and Lusha Xiang, and Jennifer A Dearman, and Cory B Carter, and Robert L Hester
July 1990, Metabolism: clinical and experimental,
Copied contents to your clipboard!